跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMETASONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MOMETASONE
Authorized
STANDARD
MOMETASONE
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a641f79765383459
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
a641f79765383459
Drug Approval Canada Name
MOMETASONE
Product Name
MOMETASONE
Status
Marketed
Status Date
2022-05-30
Original Market Date
2022-05-30
Din
02519127
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
Prescription
Ahfs
52:08.08
Atc Original
R01AD09 MOMETASONE
Atc Name
r 01 ad 09
Aig Number
0121732002
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE)
50 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a641f79765383459
Type
Standard
Back to Health Canada Approvals